Two Neds—Ned David and Ned Sharpless—form Jupiter Bioventures and close $70M in initial financing

KRAS mutation is a significant predictor of metastasis and survival in pancreatic cancer, study shows

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic mutation—KRAS circulating tumor DNA—strongly indicates a higher risk of cancer spread and worse survival rates for patients with pancreatic ductal adenocarcinoma.

March 21, 2025

Vol.51 No.11

Clinical Roundup

Self-driving microscope solves previous challenges in microscopy

UT Southwestern Medical Center researchers developed a “self-driving” microscope that solves two challenges that have long plagued microscopy: 1) imaging living cells or organisms at dramatically different scales, and 2) following a specific structure or area of interest over long periods of time.

March 14, 2025

Vol.51 No.10

Clinical Roundup

Tumor-invading protein delivers therapy straight to the brain, study finds

A protein designed by Cedars-Sinai Cancer investigators can cross the protective blood-brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.

February 28, 2025

Vol.51 No.08

In Brief

Ze’ev Ronai receives NCI Outstanding Investigator Award

Ze’ev Ronai, a cancer investigator and director of the Translational Research Institute at Cedars-Sinai, received an Outstanding Investigator Award from NCI.

February 21, 2025

Vol.51 No.07

Clinical Roundup

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Cedars-Sinai performed the first robot-assisted microsurgical head-and-neck cancer reconstructive surgery in the United States after the robot device received FDA approval for the procedure.

February 21, 2025

Vol.51 No.07

Clinical Roundup

Mayo Clinic researchers identify new immunotherapy target for ovarian cancer

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science Advances, could improve treatment approaches for this type of cancer.

February 21, 2025

Vol.51 No.07

Two Neds—Ned David and Ned Sharpless—form Jupiter Bioventures and close $70M in initial financing

YOU MAY BE INTERESTED IN

KRAS mutation is a significant predictor of metastasis and survival in pancreatic cancer, study shows

Self-driving microscope solves previous challenges in microscopy

Tumor-invading protein delivers therapy straight to the brain, study finds

Ze’ev Ronai receives NCI Outstanding Investigator Award

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Mayo Clinic researchers identify new immunotherapy target for ovarian cancer

Renew today!

Subscriber content

Never miss an issue!

Login